IR Press

PTA-Adhoc: Dr. Hönle AG: Hönle Group adjusts forecast for the 2022/2023 FY and provides outlook on the 2023/2024 FY

Gilching (pta044/05.12.2023/20:00) – The Management Board expected for the Hönle Group, sales of €100 million to €105 million, an adjusted operating result (EBIT adjusted) of €5.5 million to €6.5 million and an operating result (EBIT ) between €7 million and €8 million in the 2022/2023 financial year. Based on current knowledge, the Management Board expects sales and adjusted operating profit (EBIT adjusted) for the Hönle Group, each to be slightly above the target corridors in the 2022/2023 financial year. The operating result (EBIT) is expected to be about €2 million below the target corridor.

PTA-News: Dr. Hönle AG: Dr. Markus Arendt becomes Managing Director of Dr. Hönle AG

Gilching (pta026/20.10.2023/18:30) – The Supervisory Board of Dr. Hönle AG intends to appoint Dr. Markus Arendt as a member of the Management Board of Dr. Hönle AG with effect presumably from May 1st, 2024. He will follow Dr. Franz Richter, who was delegated to the Management Board by the Supervisory Board and will be leaving the Management Board when a successor is appointed.

PTA-Adhoc: Dr. Hönle AG: Dr. Markus Arendt becomes Managing Director of Dr. Hönle AG

Gilching (pta022/20.10.2023/17:35) – The Supervisory Board of Dr. Hönle AG intends to appoint Dr. Markus Arendt as a member of the Management Board of Dr. Hönle AG with effect presumably from May 1st, 2024. He will follow Dr. Franz Richter, who was delegated to the Management Board by the Supervisory Board and will be leaving the Management Board when a successor is appointed.

PTA-News: Dr. Hönle AG: Hönle generated an adjusted operating result of €5.0 million in nine months

Gilching (pta011/07.08.2023/08:30) – * Still high order backlog * Revenue decreases by 8.5% to €79.7 million due to a drop in revenue in the air sterilization sector * Discontinuation of the product line of mobile air disinfection systems and the resignation of a member of the Management Board lead to negative one-off effects totalling €11.9 million in Q3 * Operating result (EBIT) falls to €-6.8 million (PY: €9.6 million) * Adjusted operating result is €5.0 million (PY: €9.0 million) * Forecast for the 2022/23 financial year confirmed

Scroll to Top